Innovations in Infectious Diseases & Vaccines Clinical Development – Highlights from ESCMID Global 2024
Medpace infectious diseases and vaccines experts share key takeaways from ESCMID Global 2024 in Barcelona, Spain.
Medpace Expands Medical Leadership Team in Asia Pacific
Medpace is pleased to announce the addition of four experienced medical experts, Dr. Shinichi Asabe, Dr. Morihiro Watanabe, Dr. Kiyoshi...
[Webinar] Women’s Health Month Panel
On May 28th, International Day of Action for Womens Health, the Medpace Women’s Health Leadership team is hosting a webinar panel entitled, “The Evolving Women's…
Late Breaking Science: Q&A with Leading Cardiovascular Experts
From protocol development to timely recruitment and retention to regulatory approval, it is crucial that trial subjects feel involved, retain their autonomy, and understand the…
The Medpace Data Integrity Unit
Learn about our team comprised of highly trained microbiology specialists that provide ongoing evaluation and oversight of the microbiology aspects of infectious diseases studies.
Medpace Expands Oncology Medical Leadership Team
Medpace is pleased to announce the addition of new Oncology expert, Dr. Amanda Goldrick, to the Medical Leadership team.
Emerging Trends in Ophthalmology – A Look into the Clinical Development Landscape
Ophthalmology is a growing therapeutic area in clinical development, reflecting the advancements and increasing focus on developing solutions for retinal diseases. Learn more.
Medpace Recognizes World Obesity Day
March 4th is World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the...
Medpace Strengthens Medical Leadership Team in Neuroscience with the Addition of 2 New Physicians
Medpace is pleased to announce the addition of two new medical experts to its neuroscience medical leadership team. Our unique,...
[On-Demand Webinar] A Collaborative Approach to Advancing Access and Equity in Rare Disease Clinical Trials
Watch the on-demand webinar from Rare Disease Day 2024 to join the discussion with clinical trial experts on a collaborative approach to patient-friendly trials in…